Developmentally imprinted genes as markers for bladder tumor progression

Journal of Urology

Volumn 155, Issue 6, 1996, Pages 2120-2127

  Cooper, Mark J ^a   Fischer, Martin ^b   Komitowski, Dymitr ^b   Shevelev, Alexander ^b   Schulze, Ekkehard ^b   Ariel, Ilana ^b   Tykocinski, Mark L ^b   Miron, Stela ^b   Ilan, Joseph ^b   De Groot, Nathan ^b   Hochberg, Abraham ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b NONE

Author keywords

bladder neoplasms; genomic imprinting; insulin like growth factor II; tumor markers, biological

Indexed keywords

ONCOPROTEIN; ONCOPROTEIN H 19; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ADVANCED CANCER; ARTICLE; BLADDER TUMOR; CANCER GRADING; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; FETUS; GENOME IMPRINTING; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; NORTHERN BLOTTING; ONCOGENE; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 9344223920     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66120-2     Document Type: Article

References (64)

1. Dalbagni, G., Presti, J., Reuter, V., Fair, W. R. and Cordon-Cardo, C.: Genetic alterations in bladder cancer. Lancet, 342: 469, 1993.
2. Burchill, S. A., Neal, D. E. and Lunec, J.: Frequency of H-ras mutations in human bladder cancer detected by direct sequencing. Br. J. Urol., 73: 516, 1994.
3. Theodorescu, D., Cornil, L, Fernandez, B. J. and Kerbel, R. S.: Overexpression of normal and mutated forms of HRAS induces orthotopic bladder invasion in a human transitional cell carcinoma. Proc. Natl. Acad. Sci. U.S.A., 87: 9047, 1990.
4. Pratt, C. I., Kao, C., Wu, S.-Q., Gilchrist, K. W., Oyasu, R. and Reznikoff, C. A.: Neoplastic progression by EJ/ras at different steps of transformation in vitro of human uroepithelial cells. Cancer Res., 52: 688, 1992.
5. Lipponen, P. and Eskelinen, M.: Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis. Br. J. Cancer, 69: 1120, 1994.
6. Theodorescu, D., Cornil, I., Sheehan, C., Man, M. S. and Kerbel, R. S.: Ha-ras induction of the invasive phenotype results in up-regulation of epidermal growth factor receptors and altered responsiveness to epidermal growth factor in human papillary transitional cell carcinoma cells. Cancer Res., 51: 4486, 1991.
7. Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P. and Vogelstein, B.: Identification of p53 gene mutations in bladder cancers and urine samples. Science, 252: 706, 1991.
8. Cordon-Cardo, C., Dalbagni, G., Saez, G. T., Oliva, M. R., Zhang, Z.-F., Rosai, J., Reuter, V. E. and Pellicer, A.: p53 mutations in human bladder cancer: genotypic versus phenotypic patterns. Int. J. Cancer, 56: 347, 1994.
9. Cordon-Cardo, C., Wartinger, D., Petrylak, D., Dalbagni, G., Fair, W. R., Fuks, Z. and Reuter, V. E.: Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J. Natl. Cancer Inst., 84: 1251, 1992.
10. Goodrich, D. W., Chen, Y., Scully, P. and Lee, W.-H.: Expression of the retinoblastoma gene product in bladder carcinoma cells associates with a low frequency of tumor formation. Cancer Res., 52: 1968, 1992.
11. Babu, V. R., Luts, M. D., Miles, B. J., Farah, R. N., Weiss, L. and Van Dyke, D. L.: Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology. Cancer Res., 47: 6800, 1987.
12. Knowles, M. A., Elder, P. A., Williamson, M., Cairns, J. P., Shaw, M. E. and Law, M. G.: Allelotype of human bladder cancer. Cancer Res., 54: 531, 1994.
13. Sapienza, C.: Genome imprinting and carcinogenesis. Biochim. Biophys. Acta, 1072: 51, 1991.
14. Rainier, S., Johnson, L. A., Dobry, C. J., Ping, A. J., Grundy, P. E. and Feinberg, A. P.: Relaxation of imprinted genes in human cancer. Nature, 362: 747, 1993.
15. Ogawa, O., Eccles, M. R., Szeto, J., McNoe, L. A., Yun, K., Maw, M. A., Smith, P. J. and Reeve, A. E.: Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature, 362: 749, 1993.
16. Steenman, M. J. C., Rainier, S., Dobry, C. J., Grundy, P., Horon, I. L. and Feinberg, A. P.: Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nature Genet., 7: 433, 1994.
17. Moulton, T., Crenshaw, T., Hao, Y., Moosikasuwan, J., Lin, N., Dembitzer, F., Hensle, R., Weiss, L., McMorrow, L., Loew, R., Kraus, W., Gerald, W. and Tycko, B.: Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nature Genet., 7: 440, 1994.
18. DeChiara, T. M., Robertson, E. J. and Efstratiadis, A.: Parental imprinting of the mouse insulin-like growth factor II gene. Cell, 64: 849, 1991.
19. Bartolomei, M. S., Zemel, S. and Tilghman, S. M.: Parental imprinting of the mouse H19 gene. Nature, 351: 153, 1991.
20. Ferguson-Smith, A. C., Sasaki, H., Cattanach, B. M. and Surani, M. A.: Parental-origin-specific epigenetic modification of the mouse H19 gene. Nature, 362: 751, 1993.
21. Zhang, Y. and Tycko, B.: Monoallelic expression of the human H19 gene. Nature Genet., 1: 40, 1992.
22. Surani, M. A.: Genomic imprinting: control of gene expression by epigenetic inheritance. Curr. Opin. Cell. Biol., 6: 390, 1994.
23. Toguchida, J., Ishizaki, K., Sasaki, M. S., Nakamura, Y., Ikenaga, M., Kato, M., Sugimot, M., Kotoura, Y. and Yamamuro, T.: Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma. Nature, 338: 156, 1989.
24. Zhan, S., Shapiro, D. N. and Helman, L. J.: Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma. J. Clin. Invest., 94: 445, 1994.
25. Glaser, T., Housman, D., Lewis, W. H., Gerhard, D. and Jones, C.: A fine-structure deletion map of human chromosome lip; analysis of Jl series hybrids. Somat. Cell Mol. Genet., 15: 477, 1989.
26. Schroeder, W. T., Chao, L.-Y., Dao, D. D., Strong, L. C., Pathak, S., Riccardi, V., Lewis, R. W. and Saunders, G. F.: Nonrandom loss of maternal chromosome 11 alleles in Wilms tumors. Am. J. Hum. Genet., 40: 413, 1987.
27. Skinner, M. A., Vollmer, R., Huper, G., Abbott, P. and Iglehart, J. D.: Loss of heterozygosity for genes on lip and the clinical course of patients with lung carcinoma. Cancer Res., 50: 2302, 1990.
28. Takita, K.-I., Sato, T., Miyagi, M., Watatani, M., Akiyama, F., Sakamoto, G., Kasumi, F., Abe, R. and Nakamura, Y.: Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes. Cancer Res., 52: 3914, 1992.
29. Hao, Y., Crenshaw, T., Moulton, T., Newcomb, E. and Tycko, B.: Tumour-suppressor activity of H19 RNA. Nature, 365: 764, 1993.
30. Kondo, M., Suzuki, H., Ueda, R., Takagi, K, Takahashi, T. and Takahashi, T.: Parental origin of 11p15 deletions in human lung cancer. Oncogene, 9: 3063, 1994.
31. El-Badry, O. M., Romanus, J. A., Helman, L. J., Cooper, M. J., Rechler, M. M. and Israel, M. A.: Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J. Clin. Invest., 84: 829, 1989.
32. El-Badry, O. M., Minniti, C., Kohn, E. C., Houghton, P. J., Daughaday, W. H. and Helman, L. J.: Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma. Cell Growth Differ., 1: 325, 1990.
33. Brannan, C. I., Dees, E. C., Ingram, R. S. and Tilghman, S. M.: The product of the H19 gene may function as an RNA. Mol. Cell. Biol., 10: 28, 1990.
34. Pachnis, V., Belayew, A. and Tilghman, S. M.: Locus unlinked to a-fetoprotein under the control of the murine raf and Rif genes. Proc. Natl. Acad. Sci. U.S.A., 81: 5523, 1984.
35. Pachnis, V., Brannan, C. I. and Tilghman, S. M.: The structure and expression of a novel gene activated in early mouse embryogenesis. E.M.B.O. J., 7: 673, 1988.
36. Goshen, R., Rachmilewitz, J., Schneider, T., de Groot, N., Ariel, I., Palti, Z. and Hochberg, A.: The expression of the H-19 and IGF-2 genes during human embryogenesis and placental development. Mol. Reprod. Dev., 34: 374, 1993.
37. Lustig, O., Ariel, I., Ilan, J., Lev-Lehman, E., de Groot, N. and Hochberg, A.: Expression of the imprinted gene H19 in the human fetus. Mol. Reprod. Dev., 38: 239, 1994.
38. Biran, H., Ariel, I., de Groot, N., Shani, A. and Hochberg, A.: Human imprinted genes as oncodevelopmental markers. Tumor Biol., 15: 123, 1994.
39. Ariel, I., Lustig, O., Schneider, T., Pizov, G., Sappir, M., de Groot, N. and Hochberg, A.: The imprinted H19 gene as a tumor marker in bladder carcinoma. Urology, 45: 335, 1995.
40. Flatow, R., Rabson, A. B. and Rabson, A. S.: Tumorigenicity of T24 urinary bladder carcinoma cell sublines. Int. J. Cancer, 40: 240, 1987.
41. Komitowski, D. and Zinser, G.: Quantitative description of chromatin structure during neoplasia by the method of image processing. Anal. Quant. Cytol. Histol., 47: 178, 1985.
42. Chirgwin, J. M., Pryzbyla, A. E., MacDonald, R. J. and Rutter, W. J.: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294, 1979.
43. Rachmilewitz, J., Gileadi, O., Eldar-Geva, T., Schneider, T., de Groot, N. and Hochberg, A.: Transcription of the H19 gene in differentiating cytotrophoblasts from human placenta. Mol. Reprod. Dev., 32: 196, 1992.
44. Jansen, M., van Schaik, F. M., Ricker, A. T., Bullock, B., Woods, D. E., Gabbay, K. H., Nussbaum, A. L., Sussenbach, J. S. and Van den Brande, J. L.: Sequence of cDNA encoding human insulin-like growth factor I precursor. Nature, 306: 609, 1983.
45. Ullrich, A., Gray, A., Tam, A. W., Yang Feng, T., Tsubokawa, M., Collins, C., Henzel, W., Le Bon, T., Kathuria, S., Chen, E., Jacobs, S., Francke, U., Ramachandran, J. and Fujita-Yamaguchi, Y.: Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. E.M.B.O. J., 5: 2503, 1986.
46. Cooper, M. J., Hutchins, G. M., Cohen, P. S., Helman, L. J., Mennie, R. J. and Israel, M. A.: Human neuroblastoma tumor cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts. Cell Growth Differ., 1: 149, 1990.
47. Mostofi, F. K., Sobin, L. H. and Torloni, H.: Histologic typing of urinary bladder tumours. International histological classification of tumors. Geneva: The World Health Organization, vol. 10, 1973.
48. Rigby, C. C. and Franks, L. M.: A human tissue culture cell line from a transitional cell tumor of a urinary bladder: growth, chromosome pattern and ultrastructure. Br. J. Cancer, 24: 746, 1970.
49. Rasheed, S., Gardner, M. B., Rongey, R. W., Nelson-Rees, W. A. and Arnstein, P.: Human bladder carcinoma: characterization of two new tumor cell lines and search for tumor viruses. J. Natl. Cancer Inst., 58: 881, 1977.
50. O'Toole, C., Price, Z. H., Ohnuki, Y. and Unsgaard, B.: Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma. Br. J. Cancer, 38: 64, 1978.
51. Bubenik, J., Perlmann, P., Helmstein, K. and Moberger, G.: Cellular and humoral immune responses to human urinary bladder carcinomas. Int. J. Cancer, 5: 310, 1970.
52. Nayak, S. K., OToole, C. and Price, Z. H.: A cell line from an anaplastic transitional cell carcinoma of human urinary bladder. Br. J. Cancer, 35: 142, 1977.
53. Grossman, H. B., Wedemeyer, G., Ren, L., Wilson, G. N. and Cox, B.: Improved growth of human urothelial carcinoma cell cultures. J. Urol., 136: 953, 1986.
54. Lin, C. W., Lin, J. C. and Prout, G. R.: Establishment and characterization of human bladder tumor cell lines and sublines with different degrees of malignancy. Cancer Res., 45: 5070, 1985.
55. Elkin, M., Shevelev, A., Schulze, E., Tykocinski, M., Cooper, M. J., Ariel, I., Pode, D., Kopf, E., de Groot, N. and Hochberg, A.: The expression of the imprinted H19 and IGF-2 genes in human bladder carcinoma. F.E.B.S. Lett., 374: 57, 1995.
56. Zemel, S., Bartolomei, M. S. and Tilghman, S. M.: Physical linkage of two mammalian imprinted genes, H19 and insulin-like growth factor 2. Nature Genet., 2: 61, 1992.
57. Conover, C. A., Rosenfeld, R. G. and Hintz, R. I.: Insulin-like growth factor II binding and action in human fetal fibroblasts. J. Cell Physiol., 133: 560, 1987.
58. Spruck, C. H., Ohneseit, P. F., Gonzalez-Zulueta, M., Esrig, D., Miyao, N., Tsai, Y. C., Lerner, S. P., Schmutte, C., Yang, A. S., Cote, R., Dubeau, L., Nichols, P. W., Hermann, G. G., Steven, K., Horn, T., Skinner, D. G. and Jones, P. A.: Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res., 54: 784, 1994.
59. Bartolomei, M. S., Webber, A. L., Brunkow, M. E. and Tilghman, S. M.: Epigenetic mechanisms underlying the imprinting of the mouse H19 gene. Genes Dev., 7: 1663, 1993.
60. Rastinejad, F., Conboy, M. J., Rando, T. A. and Blau, H. M.: Tumor suppression by RNA from the 3′ untranslated region of α-tropomyosin. Cell, 75: 1107, 1993.
61. Hendrich, B. D., Brown, C. J. and Willard, H. F.: Evolutionary conservation of possible functional domains of the human and murine XIST genes. Hum. Mol. Genet., 2: 663, 1993.
62. Rastinejad, F. and Blau, H. M.: Genetic complementation reveals a novel regulatory role for 3′ untranslated regions in growth and differentiation. Cell, 72: 903, 1993.
63. Wevrick, R., Kerns, J. A. and Francke, U.: Identification of a novel paternally expressed gene in the Prader-Willi syndrome region. Hum. Mol. Genet., 3: 1877, 1994.
64. Crespi, M. D., Jurkevitch, E., Poiret, M., d'Aubenton-Carafa, Y., Petrovics, G., Kondorosi, E. and Kondorosi, A.: enod40, a gene expressed during nodule organogenesis, codes for a non-translatable RNA involved in plant growth. E.M.B.O. J., 13: 5099, 1994.